The effects of topical sodium cromoglicate on itch and flare in human skin induced by intradermal histamine: a randomised double-blind vehicle controlled intra-subject design trial

<p>Abstract</p> <p>Background</p> <p>Itch is a prominent feature of many skin diseases, particularly atopic dermatitis and cutaneous mastocytosis. Sodium cromoglicate (SCG), a chromone developed for the treatment of allergic disease has been shown to reduce the severity...

Full description

Bibliographic Details
Main Authors: Stevens Michael T, Church Martin K, Edwards Alan M
Format: Article
Language:English
Published: BMC 2011-03-01
Series:BMC Research Notes
Online Access:http://www.biomedcentral.com/1756-0500/4/47
id doaj-46f9bb5c2a134a508c16cc32ed8f3dda
record_format Article
spelling doaj-46f9bb5c2a134a508c16cc32ed8f3dda2020-11-25T01:31:28ZengBMCBMC Research Notes1756-05002011-03-01414710.1186/1756-0500-4-47The effects of topical sodium cromoglicate on itch and flare in human skin induced by intradermal histamine: a randomised double-blind vehicle controlled intra-subject design trialStevens Michael TChurch Martin KEdwards Alan M<p>Abstract</p> <p>Background</p> <p>Itch is a prominent feature of many skin diseases, particularly atopic dermatitis and cutaneous mastocytosis. Sodium cromoglicate (SCG), a chromone developed for the treatment of allergic disease has been shown to reduce the severity of itch when applied topically to subjects with atopic dermatitis. The aim of this study was to investigate whether topical sodium cromoglicate can reduce the severity of itch induced by intradermal histamine.</p> <p>Methods</p> <p>SCG was introduced into the skin of healthy volunteers both by iontophoresis and by topical application using a new 4% cutaneous emulsion (Altoderm™). The skin was then challenged with intradermal histamine. Measurements were made of severity of itch, size of wheal and flare and change in blood flux</p> <p>Results</p> <p>SCG significantly reduced the severity of itch (<it>P </it>= 0.0045) and flare (<it>P </it>= 0.0143) when delivered by iontophoresis. SCG 4% cutaneous emulsion significantly reduced severity of itch (<it>P </it>= 0.024) and flare (<it>P </it>= 0.015) in atopic subjects. Trend analysis showed increasing effect on itch with increased concentrations of SCG, which was significant (<it>P </it>= 0.046). There were no effects on wheal or blood flux.</p> <p>Conclusions</p> <p>Topically applied SCG, administered in a new cutaneous emulsion base, significantly reduced the itch and flare caused by intradermal histamine. The effect was greatest in atopic subjects and increased with the concentration of SCG in the emulsion.</p> <p>Trial registration</p> <p><a href="http://www.controlled-trials.com/ISRCTN35671014">ISRCTN35671014</a></p> http://www.biomedcentral.com/1756-0500/4/47
collection DOAJ
language English
format Article
sources DOAJ
author Stevens Michael T
Church Martin K
Edwards Alan M
spellingShingle Stevens Michael T
Church Martin K
Edwards Alan M
The effects of topical sodium cromoglicate on itch and flare in human skin induced by intradermal histamine: a randomised double-blind vehicle controlled intra-subject design trial
BMC Research Notes
author_facet Stevens Michael T
Church Martin K
Edwards Alan M
author_sort Stevens Michael T
title The effects of topical sodium cromoglicate on itch and flare in human skin induced by intradermal histamine: a randomised double-blind vehicle controlled intra-subject design trial
title_short The effects of topical sodium cromoglicate on itch and flare in human skin induced by intradermal histamine: a randomised double-blind vehicle controlled intra-subject design trial
title_full The effects of topical sodium cromoglicate on itch and flare in human skin induced by intradermal histamine: a randomised double-blind vehicle controlled intra-subject design trial
title_fullStr The effects of topical sodium cromoglicate on itch and flare in human skin induced by intradermal histamine: a randomised double-blind vehicle controlled intra-subject design trial
title_full_unstemmed The effects of topical sodium cromoglicate on itch and flare in human skin induced by intradermal histamine: a randomised double-blind vehicle controlled intra-subject design trial
title_sort effects of topical sodium cromoglicate on itch and flare in human skin induced by intradermal histamine: a randomised double-blind vehicle controlled intra-subject design trial
publisher BMC
series BMC Research Notes
issn 1756-0500
publishDate 2011-03-01
description <p>Abstract</p> <p>Background</p> <p>Itch is a prominent feature of many skin diseases, particularly atopic dermatitis and cutaneous mastocytosis. Sodium cromoglicate (SCG), a chromone developed for the treatment of allergic disease has been shown to reduce the severity of itch when applied topically to subjects with atopic dermatitis. The aim of this study was to investigate whether topical sodium cromoglicate can reduce the severity of itch induced by intradermal histamine.</p> <p>Methods</p> <p>SCG was introduced into the skin of healthy volunteers both by iontophoresis and by topical application using a new 4% cutaneous emulsion (Altoderm™). The skin was then challenged with intradermal histamine. Measurements were made of severity of itch, size of wheal and flare and change in blood flux</p> <p>Results</p> <p>SCG significantly reduced the severity of itch (<it>P </it>= 0.0045) and flare (<it>P </it>= 0.0143) when delivered by iontophoresis. SCG 4% cutaneous emulsion significantly reduced severity of itch (<it>P </it>= 0.024) and flare (<it>P </it>= 0.015) in atopic subjects. Trend analysis showed increasing effect on itch with increased concentrations of SCG, which was significant (<it>P </it>= 0.046). There were no effects on wheal or blood flux.</p> <p>Conclusions</p> <p>Topically applied SCG, administered in a new cutaneous emulsion base, significantly reduced the itch and flare caused by intradermal histamine. The effect was greatest in atopic subjects and increased with the concentration of SCG in the emulsion.</p> <p>Trial registration</p> <p><a href="http://www.controlled-trials.com/ISRCTN35671014">ISRCTN35671014</a></p>
url http://www.biomedcentral.com/1756-0500/4/47
work_keys_str_mv AT stevensmichaelt theeffectsoftopicalsodiumcromoglicateonitchandflareinhumanskininducedbyintradermalhistaminearandomiseddoubleblindvehiclecontrolledintrasubjectdesigntrial
AT churchmartink theeffectsoftopicalsodiumcromoglicateonitchandflareinhumanskininducedbyintradermalhistaminearandomiseddoubleblindvehiclecontrolledintrasubjectdesigntrial
AT edwardsalanm theeffectsoftopicalsodiumcromoglicateonitchandflareinhumanskininducedbyintradermalhistaminearandomiseddoubleblindvehiclecontrolledintrasubjectdesigntrial
AT stevensmichaelt effectsoftopicalsodiumcromoglicateonitchandflareinhumanskininducedbyintradermalhistaminearandomiseddoubleblindvehiclecontrolledintrasubjectdesigntrial
AT churchmartink effectsoftopicalsodiumcromoglicateonitchandflareinhumanskininducedbyintradermalhistaminearandomiseddoubleblindvehiclecontrolledintrasubjectdesigntrial
AT edwardsalanm effectsoftopicalsodiumcromoglicateonitchandflareinhumanskininducedbyintradermalhistaminearandomiseddoubleblindvehiclecontrolledintrasubjectdesigntrial
_version_ 1725086502884474880